Araz, M. Et Al. 2022. Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.1 , 49-56.

Araz, M., Soydal, Ç., Gündüz, P., Kırmızı, B. A., Bakırarar, B., Sak, S., ... Özkan, E.(2022). Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.1, 49-56.

Araz, MİNE Et Al. "Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?," MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.1, 49-56, 2022

Araz, MİNE Et Al. "Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?." MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.1, pp.49-56, 2022

Araz, M. Et Al. (2022) . "Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?." MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.1, pp.49-56.

@article{article, author={MİNE ARAZ Et Al. }, title={Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?}, journal={MOLECULAR IMAGING AND RADIONUCLIDE THERAPY}, year=2022, pages={49-56} }